A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. (Q36459140)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. |
scientific article |
Statements
1 reference
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. (English)
1 reference
Heinz-Josef Lenz
1 reference
Syma Iqbal
1 reference
Cathryn Rankin
1 reference
Philip J Gold
1 reference
Syed A Ahmad
1 reference
Anthony B El-Khoueiry
1 reference
Michael J Messino
1 reference
Randall F Holcombe
1 reference
Charles D Blanke
1 reference
10 May 2011
1 reference
1 reference
1595-1602
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference